Strong age dependent increase in the use of adjuvant systemic treatment for early stage breast cancer in the period 1990-2006: a population based analysis

被引：0
|
作者：
Sukef, M. P. P. [1 ]
van de Poll-Franse, L. V. [2 ]
Nieuwenhuijzen, G. A. P. [3 ]
Vreugdenhil, A. [4 ]
Herings, R. M. C. [1 ]
Coebergh, J. W. W. [2 ]
Voogd, A. C. [5 ]
机构：
[1] PHARMO Inst Drug Outcomes Res, Utrecht, Netherlands
[2] Comprehens Canc Ctr S, Eindhoven, Netherlands
[3] Catharina Hosp, Eindhoven, Netherlands
[4] Maxima Medisch Centrum, Veldhoven, Netherlands
[5] Maastricht Univ, Maastricht, Netherlands
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 07期
关键词：
D O I：
10.1016/S1359-6349(08)70569-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：123 / 123
页数：1
相关论文
共 50 条
  • [11] The Association Between Surgical Axillary Staging, Adjuvant Treatment Use and Survival in Older Women with Early Stage Breast Cancer: A Population-Based Study
    Matthew Castelo
    Rinku Sutradhar
    Neil Faught
    Danilo Giffoni M. M. Mata
    Ezra Hahn
    Lena Nguyen
    Lawrence Paszat
    Danielle Rodin
    Sabina Trebinjac
    Cindy Fong
    Eileen Rakovitch
    Annals of Surgical Oncology, 2023, 30 : 3901 - 3912
  • [12] Recent ASCO Guideline on the Use of Biomarkers for Adjuvant Systemic Therapy in Early-Stage Invasive Breast Cancer
    Copur, Mehmet S.
    Ramaekers, Ryan
    Gauchan, Dron
    Norvell, Max
    Clark, Douglas
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (32) : 3943 - +
  • [13] A strong family history of breast cancer increases the use of systemic treatment among patients with early-onset breast cancer: results from a population-based study.
    Verkooijen, HM
    Chappuis, PO
    Rapiti, E
    Vlastos, G
    Fioretta, G
    Sarp, S
    Sappino, AP
    Schubert, H
    Bouchardy, C
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S168 - S168
  • [14] Time trends in systemic adjuvant treatment of early-stage node-negative breast cancer in Quebec
    Hébert-Croteau, N
    Brisson, J
    Latreille, J
    Gariépy, G
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S15 - S16
  • [15] Outcomes of Women with Early Stage HER2 Overexpressing Breast Cancer Receiving Adjuvant Trastuzumab: A Population Based Analysis
    Seal, M. D.
    Speers, C. H.
    Gelmon, K.
    Ellard, S. L.
    Pickering, R. L.
    O'Reilly, S.
    Chia, S.
    CANCER RESEARCH, 2009, 69 (24) : 794S - 794S
  • [16] The influence of socioeconomic status and ethnicity on adjuvant systemic treatment guideline adherence for early-stage breast cancer in the Netherlands
    Kuijer, A.
    Verloop, J.
    Visser, O.
    Sonke, G.
    Jager, A.
    van Gils, C. H.
    van Dalen, T.
    Elias, S. G.
    ANNALS OF ONCOLOGY, 2017, 28 (08) : 1970 - 1978
  • [17] The use of neoadjuvant systemic therapy in early breast cancer as a guide to adjuvant treatment choices: A single institution review
    Mckie, Jessica
    Vereker, Melissa
    Gregory, Peter
    Morgan, Joanna
    David, Steven
    Taylor, Karen
    White, Michelle
    Antill, Yoland
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 129 - 129
  • [18] Comparative efficacy of neoadjuvant to adjuvant chemotherapy for the treatment of early-stage HER2 negative breast cancer: A population-based analysis.
    LeVasseur, Nathalie
    Simmons, Christine E.
    Gondara, Lovedeep
    Speers, Caroline
    Diocee, Rekha M.
    Sun, Julia
    Nichol, Alan
    Lohrisch, Caroline A.
    Chia, Stephen K. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [19] Cost effectiveness of trastuzumab in adjuvant treatment of early breast cancer: A model based analysis
    Dedes, Konstantin J.
    Szucs, Thomas D.
    Imesch, Patrick
    Fehr, Mathias K.
    Fink, Daniel
    ANNALS OF ONCOLOGY, 2006, 17 : 95 - 95
  • [20] Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study
    Debess, Jeanne
    Riis, Jens Ostergaard
    Engebjerg, Malene Cramer
    Ewertz, Marianne
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 121 (01) : 91 - 100
12345